Developer of a precision medicine platform designed to determine which drug will work better for each patient going through an autoimmune disease. The company's platform identifies which drug will work based on the patient's fundamental disease biology and the data from molecular signature tests and not based on symptoms, disease classification, or medical bias, enabling physicians to ensure that optimal treatment is prescribed from day one.